NCT05643404

Brief Summary

Left bundle branch block (LBBB) has been commonly associated with adverse cardiovascular (CV) events, but the effect of an isolated LBBB on maximal functional capacity is not well characterized. The study's main objective is to evaluate the effect of LBBB on maximum functional capacity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 8, 2022

Completed
14 days until next milestone

Study Start

First participant enrolled

December 22, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 9, 2024

Completed
Last Updated

August 21, 2024

Status Verified

September 1, 2023

Enrollment Period

1.5 years

First QC Date

November 22, 2022

Last Update Submit

August 20, 2024

Conditions

Keywords

Functional capacityCardiac dyssynchronyMyocardial deformation

Outcome Measures

Primary Outcomes (1)

  • Peak oxygen consumption

    Peak oxygen consumption at peak exercise of a maximal symptom-limited cardiopulmonary exercise testing. Units peak oxygen consumption : mL/kg/min

    Eligible patients will perform only one cardiopulmonary exercise testing on the first visit. Peak oxygen consumption will be evaluated during the procedure and compared to control patients.

Secondary Outcomes (2)

  • Left ventricular end-diastolic volume

    Eligible patients will perform only one echocardiography on the first visit. Left ventricular end-diastolic volume will be assessed during the procedure and compared to control patients.

  • Left ventricular ejection fraction

    Eligible patients will perform only one echocardiography on the first visit. Left ventricular ejection fraction will be assessed during the procedure and compared to control patients.

Study Arms (2)

Isolated LBBB

Subjects with left bundle branch block in the absence of clinically detectable heart disease

Diagnostic Test: Cardiopulmonary exercise testingDiagnostic Test: Echocardioghaphy

Matched controls without LBBB

Subjects without left bundle branch block and in the absence of clinically detectable heart disease

Diagnostic Test: Cardiopulmonary exercise testingDiagnostic Test: Echocardioghaphy

Interventions

Maximal functional capacity will be evaluated using incremental and symptom-limited cardiopulmonary exercise testing (CPET) on a bicycle ergometer, beginning with a workload of 10 W and increasing gradually in a ramp protocol at 10-W increments every 1 minute. We will define maximal functional capacity as when the patient stops pedalling because of symptoms, and the respiratory exchange ratio (RER) is ≥1.1. During exercise, patients were monitored with 12-lead electrocardiogram and blood pressure measurements every 2 minutes. Gas exchange data and cardiopulmonary variables were averages of values taken every 10 seconds. Peak oxygen consumption (PeakVO2) will be defined as the highest value of oxygen consumption during the last 20 seconds of exercise.

Isolated LBBBMatched controls without LBBB
EchocardioghaphyDIAGNOSTIC_TEST

Doppler echocardiogram examinations were performed under resting conditions using 2-dimensional echocardiography. Left ventricular end-diastolic volume and left ventricular ejection fraction will be measured according to the European Society of Echocardiography

Isolated LBBBMatched controls without LBBB

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

A total of 74 consecutive adults with a previous diagnosis of isolated left bundle branch block recruited from general practitioner outpatient clinics will be included. For each candidate with an isolated left bundle branch block, one control without a left bundle branch block and matched for age, sex, body surface area, and daily physical activity will be selected from general practitioner outpatient clinics

You may qualify if:

  • Adult \>18 years old
  • ECG criteria of left bundle branch block (for controls without left bundle branch block )
  • Provide informed consent

You may not qualify if:

  • Inability to perform a maximal baseline exercise test;
  • Structural heart disease, valve heart disease or diastolic dysfunction estimated by two-dimensional echocardiography;
  • Previous ischemic heart disease, heart failure, myocardiopathy or myocarditis
  • Effort angina during cardiopulmonary exercise testing (CPET);
  • Any moderate pulmonary disease;
  • Anaemia
  • Left ventricular ejection fraction \< 55%.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marta Peiro

Valencia, 46010, Spain

Location

Related Publications (1)

  • Palau P, Dominguez E, Minguez S, Nunez G, Santas E, Garcia-Conejo C, de Amo I, Marin P, Flor C, Lopez L, Ortega L, Gabaldon-Sanchez I, de la Espriella R, Sanchis J, Nunez J. Effect of left bundle branch block on maximal functional capacity in asymptomatic individuals without structural heart disease. Rev Esp Cardiol (Engl Ed). 2025 Nov;78(11):957-966. doi: 10.1016/j.rec.2025.03.001. Epub 2025 Mar 21. English, Spanish.

MeSH Terms

Conditions

Bundle-Branch Block

Interventions

Exercise Test

Condition Hierarchy (Ancestors)

Heart BlockArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Officials

  • Patricia Palau, MD, PhD

    Instituto de Investigacion Sanitaria INCLIVA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2022

First Posted

December 8, 2022

Study Start

December 22, 2022

Primary Completion

July 9, 2024

Study Completion

July 9, 2024

Last Updated

August 21, 2024

Record last verified: 2023-09

Locations